Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.71M Sell
38,439
-3,782
-9% -$784K 0.45% 82
2026
Q1
$9.36M Buy
42,221
+10,198
+32% +$2.54M 0.61% 65
2025
Q4
$7.75M Buy
32,023
+2,988
+10% +$764K 0.46% 80
2025
Q3
$7.25M Hold
29,035
0.51% 71
2025
Q2
$6.84M Buy
29,035
+2,655
+10% +$633K 0.47% 80
2025
Q1
$5.74M Sell
26,380
-1,569
-6% -$366K 0.46% 79
2024
Q4
$6.39M Buy
27,949
+25,620
+1,100% +$6.17M 0.43% 84
2024
Q3
$567K Buy
+2,329
New +$520K 0.04% 161
2024
Q2
Sell
-25,882
Closed -$5.13M 183
2024
Q1
$5.13M Buy
+25,882
New +$4.74M 0.44% 92

Other funds holding RMD

Sienna Gestion's RMD Position: Q2 2026 in Review

Sienna Gestion reduced its ResMed (RMD) stake by 9% in Q2 2026, selling an estimated $784K and leaving 38,439 shares worth $7.71M. The position accounts for 0.45% of the portfolio, ranked #82.

Sienna Gestion first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $9.36M in Q1 2026. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Sienna Gestion held 38,439 shares of ResMed worth $7.71M as of Q2 2026.
  • Sienna Gestion sold 3,782 ResMed shares in Q2 2026, an estimated $784K.
  • ResMed made up 0.45% of Sienna Gestion's portfolio in Q2 2026, its #82 holding.
  • Sienna Gestion first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
  • Sienna Gestion's ResMed position peaked at $9.36M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Sienna Gestion's 13F filing for Q2 2026, filed 13 Aug 2026.